pharma · Renal Insufficiency, Chronic · REVB
REVELATION BIOSCIENCES
REVELATION BIOSCIENCES, INC.
REVELATION BIOSCIENCES patent portfolio — 2 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
San Diego, USA HQ
2020 Founded
14 Employees
Public company Type
REVB · NYSE Ticker
Company details
- Status
- Public
- HQ
- San Diego, USA
- Founded
- 2020
- Employees
- 14
- Programs
- 1
- Drugs
- 1
- Patents
- 2
REVELATION BIOSCIENCES patents
2 pharmaceutical patents indexed for REVELATION BIOSCIENCES. 0 expire within 24 months.
REVELATION BIOSCIENCES has 2 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
Frequently asked questions
How many patents does REVELATION BIOSCIENCES have?
2 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do REVELATION BIOSCIENCES patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.